Matsumoto Toshihiko, Kobayashi Ohji
Center for Suicide Prevention, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira 187-8553, Japan.
Nihon Arukoru Yakubutsu Igakkai Zasshi. 2008 Jun;43(3):172-87.
Methamphetamine (MAP) has been one of the most popular abused drugs in Japan since 1950s. Nevertheless, although some of the psychiatric hospitals in Japan have treated psychosis caused by MAP, few have committed to rehabilitation for MAP dependence, which most of the individuals with MAP psychosis suffer from. This paper described the actual situation around the rehabilitation for MAP dependence in Japan, and proposed the necessity of establishing the new outpatient programs for the individuals with MAP dependence in Japan, introducing the Matrix Model, the outpatient program which has been served for individuals with MAP dependence since the middle of 1980s in the West Coast area in U.S.A. Additionally, we also introduced the principle and contents of our new outpatient program, the Serigaya Methamphetamine Relapse Prevention Program (SMARPP), which we have tried to conduct in Kanagawa Psychiatric Center Serigaya Hospital, consisting of the three a week groups sessions including relapse prevention program, motivational interviewing attitudes, and urine-monitoring following the Matrix Model. We discussed the future model of rehabilitation systems for drug dependence in Japan, and insisted that the current practices of the modified SMARPP starting in four psychiatric hospitals and one mental health and welfare center will be expected to establish the future outpatient program for MAP dependence in Japan.
自20世纪50年代以来,甲基苯丙胺(MAP)一直是日本最流行的滥用药物之一。然而,尽管日本的一些精神病院治疗过由MAP引起的精神病,但很少有医院致力于对MAP依赖进行康复治疗,而大多数患有MAP精神病的人都存在这种依赖。本文描述了日本MAP依赖康复治疗的实际情况,并提出有必要为日本的MAP依赖者建立新的门诊项目,介绍了矩阵模型,这是一种自20世纪80年代中期以来在美国西海岸地区为MAP依赖者提供服务的门诊项目。此外,我们还介绍了我们新的门诊项目——世田谷甲基苯丙胺复发预防项目(SMARPP)的原则和内容,我们已尝试在神奈川县立世田谷医院精神科中心开展该项目,该项目包括每周三次的小组会议,按照矩阵模型进行复发预防项目、动机访谈态度和尿液监测。我们讨论了日本药物依赖康复系统的未来模式,并坚持认为目前在四家精神病院和一个精神健康与福利中心开展的改良SMARPP实践有望为日本建立未来的MAP依赖门诊项目。